SCHEMBL23248569

SCHEMBL23248569

C=CC(=O)Nc1cc(Nc2ncc(Cl)c(NC(=O)c3ccccc3NS(C)(=O)=O)n2)c(OC)cc1OCCN1CCOCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 15/20 0.56
▸ MAPK3 P27361 1/20 0.54
▸ BTK Q06187 4/20 0.53
▸ JAK3 P52333 3/20 0.53
▸ LRRK2 Q5S007 2/20 0.52
▸ SRC P12931 1/20 0.51
▸ ALK Q9UM73 2/20 0.50
▸ CDC7 O00311 1/20 0.49
▸ PLK4 O00444 1/20 0.49
▸ CHEK1 O14757 1/20 0.49
▸ AURKA O14965 1/20 0.49
▸ DCLK1 O15075 1/20 0.49
▸ PDPK1 O15530 1/20 0.49
▸ DAPK3 O43293 1/20 0.49
▸ DYRK3 O43781 1/20 0.49
▸ JAK2 O60674 1/20 0.49
▸ PRKD3 O94806 1/20 0.49
▸ PAK4 O96013 1/20 0.49
▸ CHEK2 O96017 1/20 0.49
▸ ERBB2 P04626 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23255650 0.92 EGFR (0.64) EGFRMAPK3BTKJAK3LRRK2
SCHEMBL27238046 0.86 EGFR (0.66) EGFRMAPK3LRRK2ALKROS1
SCHEMBL30223016 0.86 EGFR (0.66) EGFRMAPK3LRRK2ALKROS1
SCHEMBL15600768 0.85 EGFR (0.64) EGFRBTKJAK3ALKINSR
SCHEMBL16371150 0.84 EGFR (0.71) EGFRBTKJAK3LRRK2ALK
SCHEMBL30223076 0.82 EGFR (0.55) EGFRMAPK3BTKJAK3ALK
SCHEMBL25005692 0.82 EGFR (0.55) EGFRMAPK3BTKJAK3ALK
SCHEMBL16371486 0.82 BTK (0.62) EGFRMAPK3BTKJAK3LRRK2
SCHEMBL16781014 0.81 EGFR (0.63) EGFRBTKJAK3ALKINSR
SCHEMBL23248535 0.81 EGFR (0.69) EGFRMAPK3BTKLRRK2ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021075691-A1 PYRIMIDINE DERIVATIVE, METHOD OF PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SAME AS EFFECTIVE COMPONENT 한국화학연구원 2021-04-22 — — WO claimed
WO-2021075691-A1 PYRIMIDINE DERIVATIVE, METHOD OF PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SAME AS EFFECTIVE COMPONENT 한국화학연구원 2021-04-22 — — WO disclosed
Send feedback